Drug form Zydus Cadila today said it has received final nod from the US health regulator to market Tranexamic acid injection. Zydus Cadila has... ...http://www.business-standard.com/article/pti-stories/zydus-gets-usfda-nod-to-market-tranexamic-acid-injection-117071900881_1.html
Posted by Equitymaster Asian equities are trading mixed today as investors awaited the release of China's second-quarter GDP. Hong Kong's Hang Seng... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/fmIeD5GIx8s/tm.asp
Posted by Equitymaster After opening the day on a negative note, the share markets in India continued to trade below the dotted line as investors... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/iKRLbZcYcfY/tm.asp
Zydus Group firm Cadila Healthcare today said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical... ...http://www.dnaindia.com/business/report-zydus-nesher-pharmaceuticals-gets-fda-nod-for-antifungal-drug-2467805
The company was formed way back in...